Aug 14, 2019 in Press Releases

XPhyto Therapeutics Enters Cannabis Research And Development Agreement With The Technical University Of Munich

Vancouver, Canada (August 14, 2019) – XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH (“Bunker”), has entered into an exclusive cannabis research and development agreement (the “R&D Agreement”) with the Technical University of Munich (“TUM”).

Pursuant to the R&D Agreement, initial research will focus on the identification and assessment of novel research and development approaches to utilize the cannabis plant and its derivatives, including cannabinoids, terpenes, terpenoids, polyphenols and flavones. Promising targets will be advanced through pilot studies and pending preliminary success, pursued via separate joint research projects on a case-by-case basis for potential commercialization.

“XPhyto is honored to have the privilege of working with TUM. Their commitment to research excellence and their reputation for commercial development makes them a highly attractive partner,” said Robert Barth, VP European Corporate Development, XPhyto and Managing Director, Bunker. “TUM’s strong interest in cannabis research demonstrates a progressive attitude toward an emerging and highly relevant global industry.”

We are also looking forward to start the project with our research-oriented partner of Bunker Pflanzenextrakte GmbH. This longterm orientated cooperation will enable us to compare the phytochemical profiles and their biochemical properties of cannabis varieties soon. Among other things, this should create the conditions for exploiting the full potential of the highly active ingredients for the treatment of serious diseases in a targeted and individual manner,” says Prof. Dr. Wolfgang Eisenreich from the Faculty of Chemistry at the Technical University of Munich.

TUM has a reputation as an entrepreneurial institution and is the only technical university in Germany to be recognized as one of the country’s “Universities of Excellence” every year since the program began in 2006. TUM has achieved success in all three lines of funding under the Excellence Initiative organized by the German government and the federal states: Institutional Strategy, Clusters of Excellence and Graduate Schools